Stammdaten
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases. The company is headquartered in Tel Aviv-Jaffa, Israel.
Unternehmen & Branche
| Name | Raphael Pharmaceutical Inc. |
|---|---|
| Ticker | RAPH |
| CIK | 0001415397 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - Specialty & Generic |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 1,0 Mio. USD |
| Beta | 2,66 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -1,279,000 | 0.07 | 53,000 | -1,433,000 | |
| 2025-09-30 | 10-Q | -255,000 | 0.01 | 7,000 | -1,264,000 | |
| 2025-06-30 | 10-Q | -322,000 | 0.02 | 30,000 | -1,048,000 | |
| 2025-03-31 | 10-Q | -429,000 | 0.02 | 93,000 | -734,000 | |
| 2024-12-31 | 10-K | -1,519,000 | 0.08 | 27,000 | -742,000 | |
| 2024-09-30 | 10-Q | -326,000 | 0.01 | 51,000 | -616,000 | |
| 2024-06-30 | 10-Q | -248,000 | 0.01 | 128,000 | -290,000 | |
| 2024-03-31 | 10-Q | -550,000 | 0.03 | 353,000 | -103,000 | |
| 2023-12-31 | 10-K | -1,344,000 | 0.08 | 239,000 | 107,000 | |
| 2023-09-30 | 10-Q | -725,000 | 0.04 | 403,000 | -75,000 | |
| 2023-06-30 | 10-Q | -417,000 | 0.03 | 119,000 | -61,000 | |
| 2023-03-31 | 10-Q | -264,000 | 0.02 | 150,000 | -9,000 | |
| 2022-12-31 | 10-K | -3,358,000 | 0.23 | 333,000 | 106,000 | |
| 2022-09-30 | 10-Q | -1,443,000 | 0.10 | 121,000 | -62,000 | |
| 2022-06-30 | 10-Q | -627,000 | 0.05 | 196,000 | 118,000 | |
| 2022-03-31 | 10-Q | -185,000 | 0.01 | 180,000 | 103,000 | |
| 2021-12-31 | 10-K | -1,624,000 | 0.14 | 422,000 | 128,000 | |
| 2021-09-30 | 10-Q | -416,000 | 0.03 | 62,000 | -125,000 | |
| 2021-06-30 | 10-Q | -387,000 | 0.04 | 191,000 | ||
| 2021-03-31 | 10-Q | -255,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.